Orient Europharma Co

Orient Europharma Co EBIT per Share

The EBIT per Share of Orient Europharma Co (4120.TWO) as of Oct 17, 2026 is -3.44 TWD. In the previous year, EBIT per Share was 0.15 TWD — a change of -2,342.56% (lower).

EBIT per Share

-3.44TWD

YoY

-2,342.56%

Last updated:

EBIT per Share of Orient Europharma Co is 2025 -3.44 TWD. EBIT per Share of Orient Europharma Co was 2024 0.15 TWD. It decreases by -2,342.56% lower compared to the previous year.

The Orient Europharma Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
4.12 TWD
Jan 1, 2019
3.88 TWD
Jan 1, 2020
1.35 TWD
Jan 1, 2021
1.28 TWD
Jan 1, 2022
-3.22 TWD
Jan 1, 2023
0.83 TWD
Jan 1, 2024
0.15 TWD
Jan 1, 2025
-3.44 TWD
The Orient Europharma Co EBIT per Share history
YEAREBIT per ShareYoY
-3.44TWD-2,342.56%
0.15TWD-81.53%
0.83TWD-125.81%
-3.22TWD-351.98%
1.28TWD-5.46%
1.35TWD-65.12%
3.88TWD-5.82%
4.12TWD-17.97%
5.02TWD-3.09%
5.18TWD+71.07%
3.03TWD+23.47%
2.45TWD+224.00%
0.76TWD-64.28%
2.12TWD+1.63%
2.08TWD-41.65%
3.57TWD-22.92%
4.63TWD+18.84%
3.90TWD+25.99%
3.10TWD+9.91%
2.82TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd, based in Taipei City, Taiwan, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and trades western medicine, health food, and cosmetics, with a focus on nutritious healthcare products, medical cosmetic products, and western drugs. Its product segments include infant milk powders, functional healthcare items, dermatological preparations, medical hair care, organic skincare, and pharmaceuticals for conditions such as cardiovascular diseases, cancer, and diabetes. Listed on 28 November 2002. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

EBIT per Share of Orient Europharma Co is -3.44 TWD in 2025.

EBIT per Share of Orient Europharma Co changed from 0.15 TWD to -3.44 TWD, representing a -2,342.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Orient Europharma Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Orient Europharma Co